Expression of IL-18 by SIV does not modify the outcome of the antiviral immune response

11Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Interleukin 18 (IL-18) is a proinflammatory cytokine expressed by several cell types, including activated dendritic cells and macrophages, that acts in synergy with IL-12 as an important amplifying factor for IFN-γ production and Th1 development. To study the immunological and virological effects of IL-18 expression in the context of a lentiviral infection, we inoculated rhesus macaques with a high dose of replication-competent simian immunodeficiency virus (SIV) vectors carrying the rhesus IL-18 gene in the sense (SIVIL-18) or antisense (SIVFIGI) orientation. Both vectors behaved as attenuated viruses, resulting in low viral loads, induction of low and transient levels of inflammatory cytokines, no CD4+ T cell depletion, and mild activation of T lymphocytes. Although IL-18-expressing virus could be isolated from some SIVIL18-infected macaques for 12 weeks postinfection, the anti-SIV humoral and cellular immune responses of macaques inoculated with SIVIL18 and SIVFIGI were similar to each other, with the exception of an early IFN-γ response in animals infected with SIVIL18. In summary, expression of IL-18 during the acute phase of SIV infection does not increase viral replication or influence the outcome of the antiviral immune response. © 2002 Elsevier Science (USA).

Cite

CITATION STYLE

APA

Giavedoni, L. D., Velasquillo, M. C., Parodi, L. M., Hubbard, G. B., & Hodara, V. L. (2002). Expression of IL-18 by SIV does not modify the outcome of the antiviral immune response. Virology, 303(2), 327–337. https://doi.org/10.1006/viro.2002.1647

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free